Submitted by Anonymous (not verified) on 9 June 2026 - 16:06
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ultomiris, ravulizumab, Date of authorisation: 02/07/2019, Revision: 20, Status: Authorised